Company Overview

Update
Founded:
2006
Headquarters:
Cambridge, MA
Funding:
$44.80M
Categories:
Biotechnology

NeuroPhage develops disease-modifying therapies for Alzheimer’s, Parkinson’s, Huntington’s, ALS, MS and other neurodegenerative diseases.

Description

Update

NeuroPhage Pharmaceuticals, Inc., a biotechnology company, develops disease-modifying therapies for the treatment of neurodegenerative diseases. The company develops a protein disaggregation platform for the treatment of Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral and multiple sclerosis, and other neurodegenerative diseases. It offers NPT001, a drug candidate for Alzheimer’s disease to disaggregate existing plaque in preclinical animal models. The company was founded in 2006 and is headquartered in Cambridge, Massachusetts.

Current Team (1)

Update

Funding Rounds (4) - $44.80M

Update

Investors (2)

Update
  • 35c3d686e4de63ee79a626a2a44a9113

    Shire

    Shire PLC is a specialty biopharmaceutical company. They have a global sales and marketing..
  • 386e747a87ecb278c0407da8f9dbe33f

    Merieux Developpement

    Healthcare investment company

Offices/Locations (1)

Update
  • Office

    222 Third Street

    Suite 3120

    Cambridge, MA 02142

    USA

Images (1)

Update
  • Fd5c49311c3f41ccbc3412e2f38cb347